Jenny Jiang

1.2k total citations
37 papers, 854 citations indexed

About

Jenny Jiang is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Jenny Jiang has authored 37 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 9 papers in Internal Medicine and 7 papers in Epidemiology. Recurrent topics in Jenny Jiang's work include Atrial Fibrillation Management and Outcomes (16 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Cardiac Arrhythmias and Treatments (7 papers). Jenny Jiang is often cited by papers focused on Atrial Fibrillation Management and Outcomes (16 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Cardiac Arrhythmias and Treatments (7 papers). Jenny Jiang collaborates with scholars based in United States, United Kingdom and Denmark. Jenny Jiang's co-authors include Carol L. Moore, James Spalding, Gerry Oster, Charu Taneja, Marcus Zervos, Luis Felipe Reyes, Nadia Z. Haque, John Edelsberg, Jacqueline McBride and Duska M. Franic and has published in prestigious journals such as Circulation, Blood and The Journal of Immunology.

In The Last Decade

Jenny Jiang

34 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenny Jiang United States 14 218 176 171 164 147 37 854
Franz Ratzinger Austria 14 73 0.3× 33 0.2× 148 0.9× 80 0.5× 73 0.5× 41 583
Dietmar Zdunek Germany 22 86 0.4× 706 4.0× 87 0.5× 29 0.2× 63 0.4× 36 1.5k
Cristóvão Luís Pitangueira Mangueira Brazil 12 112 0.5× 39 0.2× 96 0.6× 74 0.5× 12 0.1× 48 475
Ana Konvalinka Canada 20 279 1.3× 110 0.6× 107 0.6× 209 1.3× 144 1.0× 43 1.2k
Ulla Derhaschnig Austria 26 137 0.6× 675 3.8× 277 1.6× 71 0.4× 8 0.1× 69 1.7k
J. W. Olivier van Till Netherlands 18 106 0.5× 109 0.6× 218 1.3× 32 0.2× 92 0.6× 34 1.1k
Gerardo Bozovich Argentina 9 35 0.2× 183 1.0× 144 0.8× 81 0.5× 13 0.1× 21 625
Mustafa Kaplan Türkiye 15 80 0.4× 45 0.3× 41 0.2× 83 0.5× 18 0.1× 71 955
Milind Nadkar India 14 104 0.5× 23 0.1× 151 0.9× 69 0.4× 17 0.1× 58 660
C. M. A. Bijleveld Netherlands 32 55 0.3× 81 0.5× 29 0.2× 188 1.1× 231 1.6× 99 2.6k

Countries citing papers authored by Jenny Jiang

Since Specialization
Citations

This map shows the geographic impact of Jenny Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Jiang more than expected).

Fields of papers citing papers by Jenny Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Jiang. The network helps show where Jenny Jiang may publish in the future.

Co-authorship network of co-authors of Jenny Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Jiang. A scholar is included among the top collaborators of Jenny Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Jiang. Jenny Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schauer, Stephen, Balázs István Tóth, Julie Lee, et al.. (2024). Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology. Alzheimer s & Dementia. 20(12). 8855–8866. 7 indexed citations
3.
Lip, Gregory Y.H., Amiee Kang, Xuemei Luo, et al.. (2024). Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims. Journal of Thrombosis and Thrombolysis. 57(6). 1092–1102. 1 indexed citations
4.
Deitelzweig, Steven, Amiee Kang, Jenny Jiang, et al.. (2024). Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation. Journal of Clinical Medicine. 13(4). 1073–1073. 2 indexed citations
5.
Atwater, Brett D., Manuela Di Fusco, Allison Keshishian, et al.. (2023). Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation. Journal of Thrombosis and Thrombolysis. 56(4). 626–634. 5 indexed citations
6.
Atwater, Brett D., Jennifer D. Guo, Allison Keshishian, et al.. (2023). Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation. Journal of Thrombosis and Thrombolysis. 57(1). 1–10. 2 indexed citations
7.
Liu, Xuejun, Jenny Jiang, Danshi Li, et al.. (2023). Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom. Cardiology and Therapy. 12(4). 675–687. 2 indexed citations
8.
Sheng, Xin, Courtney Schiffman, Jenny Jiang, et al.. (2023). Biomarkers of fibrosis, inflammation, and extracellular matrix in the phase 3 trial of tocilizumab in systemic sclerosis. Clinical Immunology. 254. 109695–109695. 11 indexed citations
9.
Wang, Yan, Weihua Gao, Xu Han, et al.. (2023). Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: a retrospective cohort study. Journal of Medical Economics. 26(1). 1495–1506. 8 indexed citations
10.
Kim, Jung Hyun, et al.. (2023). Trends in cardiac rehabilitation rates among patients admitted for acute heart failure in Japan, 2009–2020. PLoS ONE. 18(11). e0294844–e0294844. 1 indexed citations
11.
Lip, Gregory Y.H., Allison Keshishian, Amiee Kang, et al.. (2022). Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases. Journal of Thrombosis and Thrombolysis. 54(1). 33–46. 7 indexed citations
12.
Deitelzweig, Steven, Allison Keshishian, Amiee Kang, et al.. (2022). Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study. European Journal of Internal Medicine. 108. 37–42. 5 indexed citations
13.
Keir, Mary, Franklin Fuh, Ryan Ichikawa, et al.. (2021). Regulation and Role of αE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease. The Journal of Immunology. 207(9). 2245–2254. 39 indexed citations
14.
Deitelzweig, Steven, Allison Keshishian, Yan Zhang, et al.. (2021). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer. JACC CardioOncology. 3(3). 411–424. 32 indexed citations
15.
16.
Wei, Wenhui, et al.. (2017). Benchmarking Insulin Treatment Persistence Among Patients with Type 2 Diabetes Across Different U.S. Payer Segments. Journal of Managed Care & Specialty Pharmacy. 23(3). 278–290. 10 indexed citations
17.
Ning, Yun, Zhen Wei, Zhuo Fu, et al.. (2011). Ranolazine Increases β-Cell Survival and Improves Glucose Homeostasis in Low-Dose Streptozotocin-Induced Diabetes in Mice. Journal of Pharmacology and Experimental Therapeutics. 337(1). 50–58. 54 indexed citations
18.
Qiu, Zhihua, Yong Ying, Michael Fox, et al.. (2010). A novel homogeneous Biotin–digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum. Journal of Immunological Methods. 362(1-2). 101–111. 21 indexed citations
19.
Fu, Alex Z., et al.. (2010). Effect of Medicare Part D on Potentially Inappropriate Medication Use by Older Adults. Journal of the American Geriatrics Society. 58(5). 944–949. 18 indexed citations
20.
Franic, Duska M. & Jenny Jiang. (2006). Potentially Inappropriate Drug Use and Health‐Related Quality of Life in the Elderly. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(6). 768–778. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franz Ratzinger Breakdown of academic impact, for papers by Dietmar Zdunek Breakdown of academic impact, for papers by Cristóvão Luís Pitangueira Mangueira Breakdown of academic impact, for papers by Ana Konvalinka Breakdown of academic impact, for papers by Ulla Derhaschnig Breakdown of academic impact, for papers by J. W. Olivier van Till Breakdown of academic impact, for papers by Gerardo Bozovich Breakdown of academic impact, for papers by Mustafa Kaplan Breakdown of academic impact, for papers by Milind Nadkar Breakdown of academic impact, for papers by C. M. A. Bijleveld
Rankless by CCL
2026